Inflectra
Payments companies reported to CMS as associated with Inflectra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Inflectra, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Inflectra
These are the largest totals companies reported as associated with Inflectra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| April Armstrong | Los Angeles, CA | Dermatology | $9,819.75 |
| Raymond Cross | Baltimore, MD | Gastroenterology (Internal Medicine) | $8,018.59 |
| Aaron Farberg | Rockwall, TX | Mohs-Micrographic Surgery | $7,992.68 |
| Adelaide Hebert | Bellaire, TX | Pediatric Dermatology | $7,877.99 |
| Bharati Kochar | Boston, MA | Gastroenterology (Internal Medicine) | $7,258.44 |
| Alvin Wells | Destin, FL | Rheumatology | $7,020.08 |
| Omar Qutub | Portland, OR | Dermatology | $6,599.14 |
| Brigid Boland | San Diego, CA | Gastroenterology (Internal Medicine) | $6,144.17 |
| Paul Yamauchi | Santa Monica, CA | Dermatology | $5,492.07 |
| Timothy Ritter | Southlake, TX | Gastroenterology (Internal Medicine) | $5,485.45 |
Prescribed Inflectra?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.